{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:27Z","timestamp":1793105727348,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1488,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1476-5381.2011.01353.x","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T14:01:01Z","timestamp":1300802461000},"page":"106-118","source":"Crossref","is-referenced-by-count":25,"title":["Inhibition of the signalling kinase JAK3 alleviates inflammation in monoarthritic rats"],"prefix":"10.1111","volume":"164","author":[{"given":"Byung-Hak","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myunghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Goo","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika A","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyun","family":"Hahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong-Hun","family":"Baeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB1|cit1","doi-asserted-by":"crossref","DOI":"10.1002\/med.20202","article-title":"Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: binding aspects and implications for drug design","author":"Bhadra","year":"2010","journal-title":"Med Res Rev"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB3|cit3","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.leukres.2006.05.006","article-title":"Identification of a constitutively active mutant of JAK3 by retroviral expression screening","volume":"31","author":"Choi","year":"2007","journal-title":"Leuk Res"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/ard.2009.108159","article-title":"Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial","volume":"69","author":"Coombs","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB8|cit7","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1074\/jbc.271.9.4585","article-title":"Activation of protein kinase A inhibits interferon induction of the Jak\/Stat pathway in U266 cells","volume":"271","author":"David","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB9|cit8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0952-7915(00)00228-4","article-title":"Signaling by type I and II cytokine receptors: ten years after","volume":"13","author":"Gadina","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB10|cit9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-60761-401-2_5","article-title":"Markers of inflammation","volume":"598","author":"Germolec","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB11|cit10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB12|cit11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ptr.2399","article-title":"Pharmacological and therapeutic effects of berberis vulgaris and its active constituent, berberine","volume":"22","author":"Imanshahidi","year":"2008","journal-title":"Phytother Res"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB13|cit12","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.90599.2008","article-title":"Berberine suppresses proinflammatory responses through AMPK activation in macrophages","volume":"296","author":"Jeong","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB14|cit13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB15|cit14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/ard.2003.013276","article-title":"Activation of the STAT1 pathway in rheumatoid arthritis","volume":"63","author":"Kasperkovitz","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB16|cit15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-9-36","article-title":"NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3","volume":"9","author":"Kim","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB17|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB18|cit17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB19|cit18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2007.12.024","article-title":"The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia","volume":"582","author":"Kudlacz","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB20|cit19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","article-title":"The anti-inflammatory potential of berberine in vitro and in vivo","volume":"203","author":"Kuo","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB21|cit20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2010.08.046","article-title":"Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-\u03baB activation","volume":"648","author":"Lee","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB22|cit21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.27536","article-title":"Selective functional inhibition of JAK3 kinase is sufficient for efficacy in collagen induced arthritis in mice","volume":"62","author":"Lin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB23|cit22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/1535-7163.MCT-07-2215","article-title":"LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells","volume":"7","author":"Lipka","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB24|cit23","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.ejca.2008.07.040","article-title":"Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer","volume":"44","author":"Liu","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB25|cit24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB26|cit25","doi-asserted-by":"crossref","first-page":"27028","DOI":"10.1074\/jbc.274.38.27028","article-title":"Targeting janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis","volume":"274","author":"Malaviya","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB27|cit26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/ph3051446","article-title":"Suppression of autoimmune arthritis by small molecule inhibitors of the JAK\/STAT pathway","volume":"3","author":"Malemud","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB28|cit27","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2365","article-title":"Cartilage preservation by inhibition of janus kinase 3 in two rodent models of rheumatoid arthritis","volume":"10","author":"Milici","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB29|cit28","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway","volume":"109","author":"O'Shea","year":"2002","journal-title":"Cell"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB30|cit29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tips.2004.09.008","article-title":"Is JAK3 a new drug target for immunomodulation-based therapies?","volume":"25","author":"Papageorgiou","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB39|cit30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.11096","article-title":"Rheumatoid arthritis is a heterogenous disease. Evidence for differences in the activation of the STAT1 pathway between tissues","volume":"48","author":"van der Pouw Kraan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB32|cit31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/hmg\/2.8.1099","article-title":"The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1","volume":"2","author":"Puck","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB34|cit32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB35|cit33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB36|cit34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0306-4522(94)90361-1","article-title":"Intraspinal release of immunoreactive calcitonin gene-related peptide during development of inflammation in the joint in vivo-a study with antibody microprobes in cat and rat","volume":"62","author":"Schaible","year":"1994","journal-title":"Neuroscience"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB37|cit35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0304-3959(93)90013-F","article-title":"Behavioral and immunohistochemical changes in an experimental arthritis model in rats","volume":"55","author":"Sluka","year":"1993","journal-title":"Pain"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB38|cit36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/CAD.0b013e328330d95b","article-title":"A systematic review of the anticancer properties of berberine, a natural product from chinese herbs","volume":"20","author":"Sun","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB40|cit37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/asheducation-2009.1.636","article-title":"Therapeutic potential of JAK2 inhibitors","volume":"2009","author":"Verstovsek","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program Book"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB41|cit38","first-page":"1650","article-title":"The jak-STAT pathway in rheumatoid arthritis","volume":"32","author":"Walker","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB42|cit39","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/ard.2005.050385","article-title":"Changes in synovial tissue jak-stat expression in rheumatoid arthritis in response to successful DMARD treatment","volume":"65","author":"Walker","year":"2006a","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB43|cit40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.2005.037929","article-title":"Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis","volume":"65","author":"Walker","year":"2006b","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB44|cit41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/ard.2006.060822","article-title":"Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak\/STAT transcription factors from patients with rheumatoid arthritis","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB45|cit42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2009.04.037","article-title":"Berberine-induced decline in circulating CD31+\/CD42- microparticles is associated with improvement of endothelial function in humans","volume":"614","author":"Wang","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB47|cit43","first-page":"491","article-title":"CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders","volume":"10","author":"West","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB48|cit44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00228-005-0952-3","article-title":"Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study","volume":"61","author":"Wu","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01353.x-BIB49|cit45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The janus kinases (jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2011.01353.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-5381.2011.01353.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T04:11:08Z","timestamp":1612671068000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1476-5381.2011.01353.x"}},"subtitle":["Inhibition of JAK3 alleviates inflammation"],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01353.x","relation":{},"ISSN":["0007-1188"],"issn-type":[{"value":"0007-1188","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}